Julphar (Gulf Pharmaceutical Industries) operates as a major multinational pharmaceutical manufacturing enterprise engaged in the discovery, development, production, and global commercialization of generic and branded prescription medicines, over-the-counter products, and biotechnology formulations. Headquartered in Ras Al Khaimah, the company runs advanced manufacturing facilities specializing in various therapeutic segments, including anti-infectives, diabetes management solutions, cardiovascular care, and respiratory treatments. By leveraging state-of-the-art biotechnology infrastructure and rigorous quality control standards, Julphar supplies essential medicines to healthcare systems across the Middle East, Africa, and numerous international export markets.